1z5s
From Proteopedia
(New page: 200px<br /> <applet load="1z5s" size="450" color="white" frame="true" align="right" spinBox="true" caption="1z5s, resolution 3.01Å" /> '''Crystal structure o...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1z5s.gif|left|200px]]<br /> | + | [[Image:1z5s.gif|left|200px]]<br /><applet load="1z5s" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="1z5s" size=" | + | |
caption="1z5s, resolution 3.01Å" /> | caption="1z5s, resolution 3.01Å" /> | ||
'''Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2'''<br /> | '''Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2'''<br /> | ||
==Overview== | ==Overview== | ||
| - | SUMO-1 (for small ubiquitin-related modifier) belongs to the ubiquitin | + | SUMO-1 (for small ubiquitin-related modifier) belongs to the ubiquitin (Ub) and ubiquitin-like (Ubl) protein family. SUMO conjugation occurs on specific lysine residues within protein targets, regulating pathways involved in differentiation, apoptosis, the cell cycle and responses to stress by altering protein function through changes in activity or cellular localization or by protecting substrates from ubiquitination. Ub/Ubl conjugation occurs in sequential steps and requires the concerted action of E2 conjugating proteins and E3 ligases. In addition to being a SUMO E3, the nucleoporin Nup358/RanBP2 localizes SUMO-conjugated RanGAP1 to the cytoplasmic face of the nuclear pore complex by means of interactions in a complex that also includes Ubc9, the SUMO E2 conjugating protein. Here we describe the 3.0-A crystal structure of a four-protein complex of Ubc9, a Nup358/RanBP2 E3 ligase domain (IR1-M) and SUMO-1 conjugated to the carboxy-terminal domain of RanGAP1. Structural insights, combined with biochemical and kinetic data obtained with additional substrates, support a model in which Nup358/RanBP2 acts as an E3 by binding both SUMO and Ubc9 to position the SUMO-E2-thioester in an optimal orientation to enhance conjugation. |
==Disease== | ==Disease== | ||
| Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1Z5S is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Ubiquitin--protein_ligase Ubiquitin--protein ligase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=6.3.2.19 6.3.2.19] Full crystallographic information is available from [http:// | + | 1Z5S is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Active as [http://en.wikipedia.org/wiki/Ubiquitin--protein_ligase Ubiquitin--protein ligase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=6.3.2.19 6.3.2.19] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Z5S OCA]. |
==Reference== | ==Reference== | ||
| Line 18: | Line 17: | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
[[Category: Ubiquitin--protein ligase]] | [[Category: Ubiquitin--protein ligase]] | ||
| - | [[Category: Lima, C | + | [[Category: Lima, C D.]] |
[[Category: Reverter, D.]] | [[Category: Reverter, D.]] | ||
[[Category: e3]] | [[Category: e3]] | ||
| Line 26: | Line 25: | ||
[[Category: ubc9]] | [[Category: ubc9]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:12:18 2008'' |
Revision as of 14:12, 21 February 2008
|
Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2
Contents |
Overview
SUMO-1 (for small ubiquitin-related modifier) belongs to the ubiquitin (Ub) and ubiquitin-like (Ubl) protein family. SUMO conjugation occurs on specific lysine residues within protein targets, regulating pathways involved in differentiation, apoptosis, the cell cycle and responses to stress by altering protein function through changes in activity or cellular localization or by protecting substrates from ubiquitination. Ub/Ubl conjugation occurs in sequential steps and requires the concerted action of E2 conjugating proteins and E3 ligases. In addition to being a SUMO E3, the nucleoporin Nup358/RanBP2 localizes SUMO-conjugated RanGAP1 to the cytoplasmic face of the nuclear pore complex by means of interactions in a complex that also includes Ubc9, the SUMO E2 conjugating protein. Here we describe the 3.0-A crystal structure of a four-protein complex of Ubc9, a Nup358/RanBP2 E3 ligase domain (IR1-M) and SUMO-1 conjugated to the carboxy-terminal domain of RanGAP1. Structural insights, combined with biochemical and kinetic data obtained with additional substrates, support a model in which Nup358/RanBP2 acts as an E3 by binding both SUMO and Ubc9 to position the SUMO-E2-thioester in an optimal orientation to enhance conjugation.
Disease
Known diseases associated with this structure: Blood group, Cad system OMIM:[111730], Blood group, Sd system OMIM:[111730], Orofacial cleft 10 OMIM:[601912]
About this Structure
1Z5S is a Protein complex structure of sequences from Homo sapiens. Active as Ubiquitin--protein ligase, with EC number 6.3.2.19 Full crystallographic information is available from OCA.
Reference
Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex., Reverter D, Lima CD, Nature. 2005 Jun 2;435(7042):687-92. PMID:15931224
Page seeded by OCA on Thu Feb 21 16:12:18 2008
